Aytu BioPharma Q1 2026 Earnings Preview

* Aytu BioPharma (AYTU [https://seekingalpha.com/symbol/AYTU]) is scheduled to announce Q1 earnings results on Thursday, November 13th, after market close.
* The consensus EPS Estimate is -$0.20 [https://seekingalpha.com/symbol/AYTU/earnings/estimates] and the consensus Revenue Estimate is $12.6M (-24.0% Y/Y).
* Over the last 3 months, EPS estimates have seen 1 upward revision [https://seekingalpha.com/symbol/AYTU/earnings/revisions] and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.

MORE ON AYTU BIOPHARMA

* Aytu BioPharma, Inc. (AYTU) Q4 2025 Earnings Call Transcript [https://seekingalpha.com/article/4825293-aytu-biopharma-inc-aytu-q4-2025-earnings-call-transcript]
* Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio [https://seekingalpha.com/news/4498177-aytu-outlines-exxua-launch-targeting-22b-mdd-market-while-streamlining-adhd-portfolio]
* Aytu BioPharma GAAP EPS of -$2.93 misses by $2.88, revenue of $15.1M misses by $2.82M [https://seekingalpha.com/news/4498127-aytu-biopharma-gaap-eps-of-2_93-misses-by-2_88-revenue-of-15_1m-misses-by-2_82m]
* Seeking Alpha’s Quant Rating on Aytu BioPharma [https://seekingalpha.com/symbol/AYTU/ratings/quant-ratings]
* Historical earnings data for Aytu BioPharma [https://seekingalpha.com/symbol/AYTU/earnings]